A further study identified disseminated tumor cells from bone marrow and lymph nodes in patients with esophageal cancer and, although the primary tumors predominantly expressed high levels of EPCAM, EPCAM expression was only observed in 37% of disseminated tumor cells from bone marrow aspirates (60). This evidence concerns the gene EPCAM and esophageal cancer.